日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Siddha COVID Care Centers in Tamil Nadu, India: Coverage, Workload, and Knowledge Gaps

印度泰米尔纳德邦悉达新冠护理中心：覆盖范围、工作量和知识差距

期刊:Cureus Journal of Medical Science
影响因子:1.3
doi:10.7759/cureus.78369
Natarajan, Shanmugasundaram; Anbarasi, Chandrasekaran; Sendhilkumar, Muthappan; Rajalakshmi, Elumalai; Ranganathan, Sasirekha; Rahamathullah, Siddique Ali T; Devasenapathy, Sasikumar; Murugan, Pitchiahkumar; P, Manickam
微生物学
新冠
发表日期：2025
文献求助 收藏

Kabasura Kudineer (KSK), a poly-herbal Siddha medicine, reduced SARS-CoV-2 viral load in asymptomatic COVID-19 individuals as compared to vitamin C and zinc supplementation: findings from a prospective, exploratory, open-labeled, comparative, randomized controlled trial, Tamil Nadu, India

一项在印度泰米尔纳德邦开展的前瞻性、探索性、开放标签、比较性、随机对照试验表明，与补充维生素C和锌相比，卡巴苏拉库迪尼尔（Kabasura Kudineer，简称KSK）这种复方草药悉达药物能够降低无症状COVID-19患者的SARS-CoV-2病毒载量。

期刊:Trials
影响因子:2
doi:10.1186/s13063-021-05583-0
Natarajan, S; Anbarasi, C; Sathiyarajeswaran, P; Manickam, P; Geetha, S; Kathiravan, R; Prathiba, P; Pitchiahkumar, M; Parthiban, P; Kanakavalli, K; Balaji, P
微生物学
SARS-CoV-2
发表日期：2021
文献求助 收藏

The efficacy of Siddha Medicine, Kabasura Kudineer (KSK) compared to Vitamin C & Zinc (CZ) supplementation in the management of asymptomatic COVID-19 cases: A structured summary of a study protocol for a randomised controlled trial

比较悉达医学卡巴苏拉库迪尼尔 (KSK) 与维生素 C 和锌 (CZ) 补充剂在治疗无症状 COVID-19 病例中的疗效：一项随机对照试验研究方案的结构化摘要

期刊:Trials
影响因子:2
doi:10.1186/s13063-020-04823-z
Natarajan, S; Anbarasi, C; Sathiyarajeswaran, P; Manickam, P; Geetha, S; Kathiravan, R; Prathiba, P; Pitchiahkumar, M; Parthiban, P; Kanakavalli, K; Balaji, P
发表日期：2020
文献求助 收藏